Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
Palatin Technologies, Inc. (PTN) will announce its Q4 and fiscal year end 2021 operating results on September 29, 2021, prior to the market opening. A conference call will follow at 11:00 a.m. ET, providing a review of the operating results and updates on ongoing programs. Investors can access the audio webcast through Palatin's website. This announcement is pivotal as it provides insight into the company's financial performance and strategic direction for potential investors.
- None.
- None.
CRANBURY, N.J., Sept. 24, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2021 operating results on Wednesday, September 29, 2021, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 29, 2021, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q4 & Fiscal Year End 2021 Results Press Release | 9/29/2021 at 7:30 a.m. ET |
Q4 & Fiscal Year End 2021 Conference Call-Live | 9/29/2021 at 11:00 a.m. ET |
US/Canada Dial-In Number: | 1-800-437-2398 |
International Dial-In Number: | 1-856-344-9206 |
Conference ID: | 3395813 |
Q4 & Fiscal Year End 2021 Conference Call-Replay | 9/29/2021-10/06/2021 |
US/Canada Dial-In Number: | 1-888-203-1112 |
International Dial-In Number: | 1-719-457-0820 |
Replay Passcode: | 3395813 |
Audio Webcast Live and Replay Access | |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-fourth-quarter-and-fiscal-year-end-2021-results-teleconference-and-webcast-to-be-held-on-september-29-2021-301384555.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies report its Q4 2021 results?
What time is the Palatin Technologies conference call for Q4 2021 results?
How can I access the Palatin Technologies Q4 2021 results webcast?
What is the significance of Palatin's upcoming Q4 2021 results?
